Cargando…

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Burkina Faso: an open label trial

Background: Malaria during pregnancy is a major health risk for both the mother and the foetus. Pregnancy has been shown to influence the pharmacokinetics of a number of different antimalarial drugs. This might lead to an under-exposure in these patients which could increase the risk of treatment fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Birgersson, Sofia, Valea, Innocent, Tinto, Halidou, Traore-Coulibaly, Maminata, Toe, Laeticia C., Hoglund, Richard M., Van Geertruyden, Jean-Pierre, Ward, Stephen A., D’Alessandro, Umberto, Abelö, Angela, Tarning, Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974929/ https://www.ncbi.nlm.nih.gov/pubmed/32025570 http://dx.doi.org/10.12688/wellcomeopenres.14849.2

Ejemplares similares

Age-modified factors associated with placental malaria in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2022)

Fetal biometry assessment with Intergrowth 21st’s and Salomon’s equations in rural Burkina Faso
por: Bihoun, Biébo, et al.
Publicado: (2020)

Prospective observational study to evaluate the clinical and biological safety profile of pyronaridine–artesunate in a rural health district in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2015)

Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso
por: Natama, Hamtandi Magloire, et al.
Publicado: (2020)

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016)

Malaria and curable sexually transmitted and reproductive tract coinfection among pregnant women in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2021)

Malaria and curable sexually transmitted infections in pregnant women: A two-years observational study in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2020)

Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study
por: Natama, Hamtandi Magloire, et al.
Publicado: (2018)

High adherence level to artemisinin-based combination therapies in rural settlement 11 years after their introduction in the health system, Nanoro, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Genetic variation in the immune system and malaria susceptibility in infants: a nested case–control study in Nanoro, Burkina Faso
por: Natama, Hamatandi Magloire, et al.
Publicado: (2021)

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria
por: Morris, Carrie A, et al.
Publicado: (2011)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2020)

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
por: Gansané, Adama, et al.
Publicado: (2021)

Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial
por: Sondo, Paul, et al.
Publicado: (2015)

Asymptomatic malaria and anaemia among pregnant women during high and low malaria transmission seasons in Burkina Faso: household-based cross-sectional surveys in Burkina Faso, 2013 and 2017
por: Rouamba, Toussaint, et al.
Publicado: (2021)

Home consumption of two fortified balanced energy protein supplements by pregnant women in Burkina Faso
por: de Kok, Brenda, et al.
Publicado: (2021)

The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso
por: Tinto, Halidou, et al.
Publicado: (2014)

An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso
por: Valea, Innocent, et al.
Publicado: (2012)

Seasonal patterns of malaria, genital infection, nutritional and iron status in non-pregnant and pregnant adolescents in Burkina Faso: a secondary analysis of trial data
por: Roberts, Stephen A., et al.
Publicado: (2021)

Different approaches for delivery of Intermittent Preventive Treatment (IPT) to pregnant women in Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2010)

Association of malaria and curable sexually transmitted infections with pregnancy outcomes in rural Burkina Faso
por: Zango, Serge Henri, et al.
Publicado: (2021)

Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2020)

Prevalence and risk factors of malaria among first antenatal care attendees in rural Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2022)

Household costs associated with seeking malaria treatment during pregnancy: evidence from Burkina Faso and The Gambia
por: Duval, Laetitia, et al.
Publicado: (2022)

Magnitude of low birthweight in malaria endemic settings of Nanoro, rural Burkina Faso: a secondary data analysis
por: Lingani, Moussa, et al.
Publicado: (2021)

Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine
por: Tahita, Marc C., et al.
Publicado: (2015)

Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2018)

Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
por: Sondo, Paul, et al.
Publicado: (2021)

Fortified Balanced Energy-Protein Supplements Increase Nutrient Adequacy without Displacing Food Intake in Pregnant Women in Rural Burkina Faso
por: de Kok, Brenda, et al.
Publicado: (2021)

Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania
por: Baiden, Rita, et al.
Publicado: (2015)

Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial
por: Nambozi, Michael, et al.
Publicado: (2015)

Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso
por: Natama, Hamtandi Magloire, et al.
Publicado: (2023)

Seasonality and Day-to-Day Variability of Dietary Diversity: Longitudinal Study of Pregnant Women Enrolled in a Randomized Controlled Efficacy Trial in Rural Burkina Faso
por: Hanley-Cook, Giles T, et al.
Publicado: (2022)

Rubella seroprevalence among pregnant women in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2013)

Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso
por: Ruizendaal, Esmée, et al.
Publicado: (2017)

Intermediate hepatitis B virus infection prevalence among 1622 pregnant women in rural Burkina Faso and implications for mother-to-child transmission
por: Ouoba, Serge, et al.
Publicado: (2023)

In Vivo Antiplasmodial Activity of Two Sahelian Plant Extracts on Plasmodium berghei ANKA Infected NMRI Mice
por: Bonkian, Léa Nadège, et al.
Publicado: (2018)

Low birth weight and its associated risk factors in a rural health district of Burkina Faso: a cross sectional study
por: Lingani, Moussa, et al.
Publicado: (2022)

Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_17t32k53qc0sqml2ltnusd4u87